A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.

Akarsu, Aysegül; Halaçli, Sevil; Tan, Çagman; Kuskonmaz, Baris; Küpesiz, Alphan; Çetinkaya, Duygu; Sanal, Özden; Tezcan, Ilhan; Çagdas, Deniz

Akarsu, Aysegül; Halaçli, Sevil; Tan, Çagman; Kuskonmaz, Baris; Küpesiz, Alphan; Çetinkaya, Duygu; Sanal, Özden; Tezcan, Ilhan; Çagdas, Deniz.

Affiliation

Akarsu A; Hacettepe University Faculty of Medicine, Department of Pediatric Immunology, Ankara, Turkey.
Halaçli S; Hacettepe University, Health Science Institute, Institute of Child Health, Department of Pediatric Immunology, Ankara, Turkey.
Tan Ç; Hacettepe University, Health Science Institute, Institute of Child Health, Department of Pediatric Immunology, Ankara, Turkey.
Kuskonmaz B; Hacettepe University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Turkey.
Küpesiz A; Akdeniz University Faculty of Medicine, Department of Pediatric Hematology, Antalya, Turkey.
Çetinkaya D; Hacettepe University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Turkey.
Sanal Ö; Hacettepe University Faculty of Medicine, Department of Pediatric Immunology, Ankara, Turkey.
Tezcan I; Hacettepe University Faculty of Medicine, Department of Pediatric Immunology, Ankara, Turkey.
Çagdas D; Hacettepe University Faculty of Medicine, Department of Pediatric Immunology, Ankara, Turkey.

Scand J Immunol ; 96(5): e13213, 2022 Nov.

Article de En | MEDLINE | ID: mdl-36808635

Sujet(s)
Mots clés

AID; CD40; CD40L; arthritis; eosinophilia

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome d'hyper-IgM / Neutropénie Limites: Humans Langue: En Journal: Scand J Immunol Année: 2022 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google